Scott Gottlieb to Newly Confirmed Head of the FDA & HSPH Interview with Margaret Hamburg, 21st Commissioner of the U.S. Food and Drug, 5/9/2017
Reporter: Aviva Lev-Ari, PhD, RN
WATCH VIDEO
Margaret Hamburg, 21st Commissioner of the U.S. Food and Drug Administration
Public Health Leadership in Challenging Times: Learning from the Past and Preparing for the Future
Tuesday, May 9, 2017
Margaret Hamburg is an internationally recognized leader in public health and medicine, where she is known for advancing regulatory science and modernizing regulatory pathways. From 2009-2015 she served as the 21st Commissioner of the U.S. Food and Drug Administration. She was also the founding vice president and senior scientist at the Nuclear Threat Initiative, a foundation dedicated to reducing nuclear, chemical and biological threats. Other positions have included Assistant Secretary for Planning and Evaluation (HHS), Health Commissioner for New York City, and Assistant Director of the National Institute of Allergy and Infectious Disease.
SOURCE
Senate Confirms Scott Gottlieb to Head F.D.A.
At his confirmation hearing in April, Dr. Gottlieb told senators that he believed in upholding the F.D.A.’s reputation as the world’s “gold standard” for drug approval. If confirmed, he said then, he would be “an absolutely objective regulatory watchdog” and would not do anything that could “besmirch the agency” or undermine public confidence in its work.
One of Dr. Gottlieb’s biggest jobs will be putting in place the 21st Century Cures Act, a law signed by President Barack Obama late last year that directs the F.D.A. to speed up drug approvals. He also said he would make addressing the nation’s opioid epidemic a top priority.
SOURCE
Leave a Reply